Concepedia

R. Li

RL

Statistics

Publications

1

Citations

32

H-Index

1

Active since

2007

Affiliations

Bristol-Myers Squibb (South Korea)(Current)

R. Li is an author at Bristol-Myers Squibb (South Korea) specializing in cancer therapeutics, cancer research, and drug resistance.

Top concepts

Publications per year

2007–2007

1

Publications

1

Phase III trial of ixabepilone plus capecitabine compared to capecitabine alone in patients with metastatic breast cancer (MBC) previously treated or resistant to an anthracycline and resistant to taxanes

Linda T. Vahdat, E. Donnall Thomas, R. Li et al. · Journal of Clinical Oncology · 2007 · 32 citations

, , +14

1–1 of 1